Scar Treatment Market analysis report by Future Market Insights shows that global sales of the Scar Treatment Market in 2021 were held at US$ 13 Billion. With a CAGR of 13.6% from 2022 to 2032, the market is projected to cross US$ 52 Billion by 2032. Market through Hospitals is expected to gross the highest revenue and is projected to grow at a CAGR of over 15% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Scar Treatment Market (2022) | US$ 14.6 Billion |
| Global Scar Treatment Market (2032) | US$ 52.2 Billion |
| Global Scar Treatment Market CAGR (2022 to 2032) | 13.6% |
| US Scar Treatment Market (2022 to 2032) | 13.8% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Scar Treatment Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market increased at around 11.9% CAGR.
Based on products, the scar treatment industry is rapidly being affected by topical products such as creams, gels, silicon sheets, and other topical products. This particular segment is expected to expand at a CAGR of 14.2% through 2032.
The treatment of scars often entails the application of topical creams, gels, and creams that are widely accessible in different medical stores. The scar therapy stimulates the skin's natural healing process by replacing collagen, elastin, and other fiber components. This allows the cured wounded surface to expand around the surrounding area. Because most such scars are the consequence of pimples, the usage of these creams reduces the appearance of the scars. As the desire for aesthetic appeal grows, so does the market for such topical medications to treat papyraceous scars.
The major impact contributing to the increasing need for scar treatment solutions is the increasing frequency of vehicle accidents. According to the Population Reference Bureau (PRB), approximately 50 million people are injured in traffic accidents every year, frequently resulting in scarring that necessitates surgical treatment. Furthermore, individuals who have such operations have surgery scars and are given topical medications to enhance and minimize their look. As a result, the increasing prevalence of traffic accidents, along with the growing number of aesthetic procedures, is projected to drive the demand for topical scar therapy solutions.
Additionally, some other factors such as the increased prevalence of skin illnesses like eczema, teratoma, photoaging, and vitiligo among the world's senior population, organically grown product introductions in the market, as well as strong promotional activities by service providers together with rising public knowledge about skin health, drives the market expansion.
The increased aesthetic sensibility of the global population has resulted in the widespread use of skin treatments. Furthermore, improved access to dermatological facilities, as well as the advent of treatments combining both pharmaceutical and natural substances, are increasing the overall need for this service. Dermatological clinics provide accurate and cutting-edge technical treatments for cosmetic surgery that provide significant results while causing the patient the least discomfort.
Principal Consultant
As the industry consolidates, key businesses are focusing on mergers and takeovers to explore the potential in this field. For example, in January 2021, Smith & Nephew PLC, the worldwide medical technology company, announced the completion of its takeover of the Extremity Orthopaedics unit of Integra Life Sciences Holdings Corporation for US$ 240 million. On the other hand, leading players are also focusing on improving their commercialization activities by adhering to administrative requirements.
During the projected period, North America is expected to hold the largest share in the global Scar Treatment Market with a projected market valuation of over US$ 16 Billion by 2032. The roadways in the United States are among the most congested in the world. According to the Centers for Disease Control (CDC), around three million people in the United States are wounded in vehicle accidents each year. Furthermore, the National Highway Traffic Safety Administration (NHTSA) estimates that 5 to 6 million vehicle accidents occur in the United States each year. It now maintains the largest proportion of the global markets and is expected to maintain this trend in the coming years, which further leads to the Scar Treatment Market expansion.
Another factor driving market expansion in the region is growing aesthetic consciousness among the country's population, which has resulted in greater use of scar treatment solutions.
Due to the increasing rate of scar treatment expenditure in South Korea, Japan, and China and factors such as the growing number of burn cases, road accidents, and skin diseases, the market in the Asia Pacific is projected to grow at the fastest rate throughout the projection period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
US Scar Treatment Market Analysis
The United States is expected to account for the largest market of US$ 15.8 Billion by the end of 2032. The rising disposable income is the primary reason for the increased expenditure on personal care items. The rising frequency of accidents seen across the country, along with well-planned hospital infrastructure boosts business expansion.
Furthermore, the region's increased appearance consciousness has resulted in an increase in the usage of innovative scar therapy services and goods. Also, the rising prevalence of skin illnesses and burning cases in this region is driving up demand for scar therapy solutions.
UK Scar Treatment Market Analysis
The market for scar treatment in the UK is projected to reach a valuation of US$ 2.6 Billion by 2032. Growing at a CAGR of 15.6% from 2022 to 2032, the market is expected to gross an absolute dollar opportunity of US$ 2 Billion.
Japan Scar Treatment Market Analysis
In Japan, the market is expected to surge at a CAGR of 14.8% during the forecast period to reach a valuation of US$ 2.9 Billion by 2032. From 2022 to 2032, the market in the country is likely to garner an absolute dollar opportunity of US$ 2.2 Billion.
South Korea Scar Treatment Market Analysis
The market in South Korea is expected to reach a valuation of US$ 1.5 Billion by 2032. With a CAGR of 15.3% during the forecast period, the market in the country is likely to register an absolute dollar opportunity of US$ 1.1 Billion.
The topical products segment is forecasted to grow at a CAGR of over 14% from 2022 to 2032. This is because creams reduce, smoothen, flatten, and diminish both old and new scars, as well as prevent the creation of new scars, which leads to a larger acceptability of creams and gels for healing scars such as burns, acne, and surgical scars in the market. It is also widely available, inexpensive, has fewer adverse effects, and is simple to use.
Hospitals commanded the largest revenue as well as CAGR of nearly 15.2% during the forecast period. The great majority of scar therapy is accessible in hospitals, giving patients a variety of choices for reducing or removing the scar. In the majority of situations, hospitals give first emergency care to patients, typically treating severe burn injuries, cuts, and wounds, as well as other serious ailments.
Some of the key players in the scar treatment market include Smith & Nephew PLC, Lumenis, Merz Pharmaceuticals LLC, Sonoma Pharmaceuticals Inc, Cynosure, Avita Medical Limited, HRA Pharma, Beijing Toplaser Technology Company Limited, and Pacific World Corporation.
Some of the recent developments of key Scar treatment service providers are as follows:
Similarly, recent developments related to companies Scar Treatment Market have been tracked by the team at Future Market Insights, which are available in the full report.
At present, the scar treatment market is valued at around US$ 13 billion.
The value of the Scar Treatment Market is projected to increase at a CAGR of around 13.6% from 2022 to 2032.
The value of the Scar Treatment Market increased at a CAGR of around 11.9% from 2017 to 2021.
The rising incidence rate of skin-related diseases, burn cases, and road accidents, as well as rising consumer awareness of numerous wound treatment options, are the primary factors shaping the market growth.
The market for Scar Treatment Market in China is projected to expand at a CAGR of around 16.3% from 2022 to 2032.
While the market in South Korea is expected to grow at nearly 15.3%, the market in Japan is projected to register a CAGR of 14.8% from 2022 to 2032.
1. Executive Summary | Scar Treatment Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Investment Feasibility Matrix 3.4. Value Chain Analysis 3.5. Regulatory Landscape 3.5.1. By Key Regions 3.5.2. By Key Countries 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032 5.3.1. Topical Products 5.3.1.1. Creams 5.3.1.2. Gels 5.3.1.3. Silicon Sheets 5.3.1.4. Other Topical Products 5.3.2. Laser Products 5.3.2.1. CO2 Laser 5.3.2.2. Pulse-dyed Laser 5.3.2.3. Other Laser Products 5.3.3. Injectables 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Scar Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Scar Type, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Scar Type, 2022 to 2032 6.3.1. Atrophic Scars 6.3.2. Hypertrophic and Keloid Scars 6.3.3. Contracture Scars 6.3.4. Stretch Marks 6.4. Y-o-Y Growth Trend Analysis By Scar Type, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By Scar Type, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2017 to 2021 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2022 to 2032 7.3.1. Hospitals 7.3.2. Clinics 7.3.3. Retail Pharmacies/ E-commerce 7.4. Y-o-Y Growth Trend Analysis By End-use, 2017 to 2021 7.5. Absolute $ Opportunity Analysis By End-use, 2022 to 2032 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia 8.3.6. Oceania 8.3.7. Middle East & Africa (MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. The US 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Scar Type 9.2.4. By End-use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Scar Type 9.3.4. By End-use 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Argentina 10.2.1.4. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Scar Type 10.2.4. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Scar Type 10.3.4. By End-use 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. The UK 11.2.1.5. Spain 11.2.1.6. Russia 11.2.1.7. BENELUX 11.2.1.8. Rest of Europe 11.2.2. By Product Type 11.2.3. By Scar Type 11.2.4. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Scar Type 11.3.4. By End-use 11.4. Key Takeaways 12. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Product Type 12.2.3. By Scar Type 12.2.4. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Scar Type 12.3.4. By End-use 12.4. Key Takeaways 13. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Thailand 13.2.1.3. Malaysia 13.2.1.4. Indonesia 13.2.1.5. Rest of South Asia 13.2.2. By Product Type 13.2.3. By Scar Type 13.2.4. By End-use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Scar Type 13.3.4. By End-use 13.4. Key Takeaways 14. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Product Type 14.2.3. By Scar Type 14.2.4. By End-use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Scar Type 14.3.4. By End-use 14.4. Key Takeaways 15. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 15.2.1. By Country 15.2.1.1. GCC 15.2.1.2. Rest of MEA 15.2.2. By Product Type 15.2.3. By Scar Type 15.2.4. By End-use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Scar Type 15.3.4. By End-use 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. The US 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2021 16.1.2.1. By Product Type 16.1.2.2. By Scar Type 16.1.2.3. By End-use 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2021 16.2.2.1. By Product Type 16.2.2.2. By Scar Type 16.2.2.3. By End-use 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2021 16.3.2.1. By Product Type 16.3.2.2. By Scar Type 16.3.2.3. By End-use 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2021 16.4.2.1. By Product Type 16.4.2.2. By Scar Type 16.4.2.3. By End-use 16.5. Argentina 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2021 16.5.2.1. By Product Type 16.5.2.2. By Scar Type 16.5.2.3. By End-use 16.6. Germany 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2021 16.6.2.1. By Product Type 16.6.2.2. By Scar Type 16.6.2.3. By End-use 16.7. Italy 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2021 16.7.2.1. By Product Type 16.7.2.2. By Scar Type 16.7.2.3. By End-use 16.8. France 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2021 16.8.2.1. By Product Type 16.8.2.2. By Scar Type 16.8.2.3. By End-use 16.9. The UK 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2021 16.9.2.1. By Product Type 16.9.2.2. By Scar Type 16.9.2.3. By End-use 16.10. Spain 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2021 16.10.2.1. By Product Type 16.10.2.2. By Scar Type 16.10.2.3. By End-use 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2021 16.11.2.1. By Product Type 16.11.2.2. By Scar Type 16.11.2.3. By End-use 16.12. BENELUX 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2021 16.12.2.1. By Product Type 16.12.2.2. By Scar Type 16.12.2.3. By End-use 16.13. China 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2021 16.13.2.1. By Product Type 16.13.2.2. By Scar Type 16.13.2.3. By End-use 16.14. Japan 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2021 16.14.2.1. By Product Type 16.14.2.2. By Scar Type 16.14.2.3. By End-use 16.15. South Korea 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2021 16.15.2.1. By Product Type 16.15.2.2. By Scar Type 16.15.2.3. By End-use 16.16. India 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2021 16.16.2.1. By Product Type 16.16.2.2. By Scar Type 16.16.2.3. By End-use 16.17. Thailand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2021 16.17.2.1. By Product Type 16.17.2.2. By Scar Type 16.17.2.3. By End-use 16.18. Malaysia 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2021 16.18.2.1. By Product Type 16.18.2.2. By Scar Type 16.18.2.3. By End-use 16.19. Indonesia 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2021 16.19.2.1. By Product Type 16.19.2.2. By Scar Type 16.19.2.3. By End-use 16.20. Australia 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2021 16.20.2.1. By Product Type 16.20.2.2. By Scar Type 16.20.2.3. By End-use 16.21. New Zealand 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2021 16.21.2.1. By Product Type 16.21.2.2. By Scar Type 16.21.2.3. By End-use 16.22. GCC Countries 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2021 16.22.2.1. By Product Type 16.22.2.2. By Scar Type 16.22.2.3. By End-use 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Scar Type 17.3.4. By End-use 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Smith & Nephew PLC 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments (Product / Age / Sales Channel / Region) 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Lumenis 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments (Product / Age / Sales Channel / Region) 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Merz Pharmaceuticals LLC 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments (Product / Age / Sales Channel / Region) 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Sonoma Pharmaceuticals Inc 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments (Product / Age / Sales Channel / Region) 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Cynosure 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments (Product / Age / Sales Channel / Region) 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Avita Medical Limited 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments (Product / Age / Sales Channel / Region) 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. HRA Pharma 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments (Product / Age / Sales Channel / Region) 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Beijing Toplaser Technology Company Limited 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments (Product / Age / Sales Channel / Region) 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Pacific World Corporation 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments (Product / Age / Sales Channel / Region) 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Scar Treatment Market
